CROs/Service Providers

inVentiv Health forms strategic alliance with Bell Medical Solutions

Tuesday, April 16, 2013 11:58 AM

inVentiv Health, a global provider of clinical, commercial and consulting services, has formed a strategic alliance with Bell Medical Solutions, a Japanese CRO with more than 700 clinical research associates serving the growing Japanese market.

More... »

BMS selects Quintiles as preferred central laboratory provider

Tuesday, April 16, 2013 10:06 AM

Quintiles, a provider of biopharmaceutical development and commercial outsourcing services, has been chosen as a preferred provider by Bristol-Myers Squibb to provide global support for BMS's central lab work, biomarker testing and assay development for the next five years.

More... »

Frazier Healthcare acquires AndersonBrecon

Monday, April 8, 2013 12:03 PM

Frazier Healthcare, a provider of growth equity and venture capital to emerging healthcare service and biopharma companies, has signed a definitive agreement to acquire AndersonBrecon, a contract pharmaceutical packaging business and wholly owned subsidiary of AmerisourceBergen. 

More... »

LabCorp Clinical Trials selected as preferred provider by BMS

Monday, April 8, 2013 11:05 AM

Laboratory Corporation of America Holdings (LabCorp) announced that LabCorp Clinical Trials has been selected as a preferred provider for full-service global central laboratory services and biomarker testing by Bristol-Myers Squibb.

More... »

inVentiv Health sells sample management business to J. Knipper

Monday, April 8, 2013 10:36 AM

J. Knipper and Company, a provider of healthcare marketing solutions, has acquired the inVentiv Health MySTRO Sample Management and Fulfillment business, including regulatory compliance, sample accountability and fulfillment services.

More... »

TranScrip Partners announce U.S. expansion

Monday, April 8, 2013 09:39 AM

TranScrip Partners, a U.K.-based CRO, has created a U.S. office. The U.S. branch of TranScrip Partners will be led by Glenn Tillotson, a pharmaceutical expert with 25 years' industry experience and a successful track record in drug development and life cycle management.

More... »

Crown Bioscience, Horizon Discovery form two-year agreement for in vivo drug discovery model development

Wednesday, April 3, 2013 11:16 AM

Crown Bioscience, a global drug discovery and development service company, and Horizon Discovery, a provider of research tools to support the development of personalized medicines, have signed an exclusive two year collaboration agreement. The relationship is a continuation of a previous collaboration between the two companies.

More... »

AG Mednet, Biovisiq team up to bring clinical trial solutions to Asian market

Wednesday, April 3, 2013 09:49 AM

Executing its mission to bring zero-delay imaging technology to clinical trials around the world, AG Mednet has signed a Master Services Agreement with Biovisiq, a Japanese imaging core laboratory (ICL), with an aim to set the new industry standard for imaging data quality, compliance and efficiency.

More... »

bioRASI completes acquisition of Sponsors Clinical Research Group

Monday, April 1, 2013 11:17 AM

bioRASI, a global full service CRO, has acquired Sponsors Clinical Research Group (SCRG), a Ukraine-based regulatory and clinical CRO. SCRG was established in 2004 and has been conducting clinical studies in an extensive range of therapeutic areas including cardiology, neurology, oncology, endocrinology and pulmonology.

More... »

Biotrial creates Biotrial Neuroscience division

Monday, April 1, 2013 10:44 AM

Biotrial, a CRO specializing in early development, has reinforced its existing CNS group through the acquisition of equipment and key talent from Forenap, a CNS-focused CRO. The new division will be called Biotrial Neuroscience.

More... »